Description
NEBULA
Description
Class IIa Medical Device (Directive 93/42/EEC).
Complete solution for the treatment of upper and lower respiratory tract ideal for the whole family. Nebula thanks to the provision of two different aerosol ampoules allows the deposition of the drug directly into the target organ (topical therapy).
Rinowash terminal for washing and treating the upper airways produces particles with a diameter of 18 mcm that are deposited in the nasal cavity up to the nasopharynx for the treatment of rhinitis, rhinosinusitis and infections of the upper respiratory tract.
Nebula Spacer nebulizer ampoule with volumetric buccal mask for the lower airways where it ensures bronchial deposition of the nebulized drug. It produces particles with a size from 1 to 5 mcm, which also reach the extreme parts such as pulmonary and bronchial alveoli.
Pediatric mask for children under 5 years for the treatment of the lower airways.
Complete therapy for upper and lower respiratory tract. Professional performance that guarantees safe and effective therapy. Low dispersion of the drug into the environment. Reduced therapy times. Resistant and long-lasting materials.
Technical specifications
- Rinowash: MMAD 18 mcm (*)
- Nebula Spacer: MMAD 1.9 mcm (*)
Minimum nebulization: 0.3 ml/min
- Device
Continuous Operation
Maximum air pressure: 2.7 bar
Maximum air flow: 12 l/min
Noise level at 1 m: 57 dBA (according to UNI EN 13544-1)
Dimensions of the basic unit: 230x180x185 mm
Weight of the basic unit: 3 kg
(*) The values indicated refer to the use of saline solution (0.9% NaCl): they may vary depending on the medicine used. The values indicated do not apply to medicines dispensed in suspension or with high viscosity. In this case, the information must be requested from the For more information, consult the user manual supplier of the medicine. Measured with API Aerosizer MACH2.
Format
1 piece.
Code 401123
Class IIa Medical Device (Directive 93/42/EEC).
Complete solution for the treatment of upper and lower respiratory tract ideal for the whole family. Nebula thanks to the provision of two different aerosol ampoules allows the deposition of the drug directly into the target organ (topical therapy).
Rinowash terminal for washing and treating the upper airways produces particles with a diameter of 18 mcm that are deposited in the nasal cavity up to the nasopharynx for the treatment of rhinitis, rhinosinusitis and infections of the upper respiratory tract.
Nebula Spacer nebulizer ampoule with volumetric buccal mask for the lower airways where it ensures bronchial deposition of the nebulized drug. It produces particles with a size from 1 to 5 mcm, which also reach the extreme parts such as pulmonary and bronchial alveoli.
Pediatric mask for children under 5 years for the treatment of the lower airways.
Complete therapy for upper and lower respiratory tract. Professional performance that guarantees safe and effective therapy. Low dispersion of the drug into the environment. Reduced therapy times. Resistant and long-lasting materials.
Technical specifications
- Rinowash: MMAD 18 mcm (*)
- Nebula Spacer: MMAD 1.9 mcm (*)
Minimum nebulization: 0.3 ml/min
- Device
Continuous Operation
Maximum air pressure: 2.7 bar
Maximum air flow: 12 l/min
Noise level at 1 m: 57 dBA (according to UNI EN 13544-1)
Dimensions of the basic unit: 230x180x185 mm
Weight of the basic unit: 3 kg
(*) The values indicated refer to the use of saline solution (0.9% NaCl): they may vary depending on the medicine used. The values indicated do not apply to medicines dispensed in suspension or with high viscosity. In this case, the information must be requested from the For more information, consult the user manual supplier of the medicine. Measured with API Aerosizer MACH2.
Format
1 piece.
Code 401123
